search
Back to results

Role of Colonic Short Chain Fatty Acids in Obesity

Primary Purpose

Obesity

Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Glucose
Inulin
Resistant Starch
Sponsored by
University of Toronto
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Obesity

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • non-pregnant
  • body mass index >=20 and <=35

Exclusion Criteria:

  • history of diabetes mellitus
  • history of cardiovascular disease
  • history of bowel disease
  • history of kidney disease
  • history of liver disease
  • use of antibiotics within 3 months of enrolment
  • unusual dietary habits
  • fasting glucose >6.9mmol/L
  • hematocrit below normal range for age and sex

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Other

    Other

    Arm Label

    Lean

    Overweight

    Arm Description

    Participants with body mass index <=25

    Participants with body mass index >25

    Outcomes

    Primary Outcome Measures

    Incremental area under the serum acetate response curve

    Secondary Outcome Measures

    Incremental area under the serum propionate response curve
    Incremental area under the serum butyrate response curve
    Incremental area under the breath hydrogen response curve
    Incremental area under the breath methane response curve
    Incremental area under the serum glucose response curve
    Incremental area under the serum glucose response curve
    Incremental area under the serum insulin response curve
    Incremental area under the serum insulin response curve
    Incremental area under the serum c-peptide response curve
    Incremental area under the serum c-peptide response curve
    Total area under the serum free-fatty acid response curve
    Total area under the serum free-fatty acid response curve

    Full Information

    First Posted
    September 25, 2015
    Last Updated
    September 28, 2015
    Sponsor
    University of Toronto
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT02562014
    Brief Title
    Role of Colonic Short Chain Fatty Acids in Obesity
    Official Title
    Effect of Inulin and Resistant Starch on Postprandial Short Chain Fatty Acid, Glucose, Insulin and Gut Hormone Responses in Lean and Overweight Subjects.
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    September 2015
    Overall Recruitment Status
    Completed
    Study Start Date
    February 2012 (undefined)
    Primary Completion Date
    July 2012 (Actual)
    Study Completion Date
    January 2013 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    University of Toronto

    4. Oversight

    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    The excess production of colonic short-chain-fatty-acids (SCFA) has been implicated in the promotion of obesity, but colonic fermentation of dietary-fiber to SCFA may also play a role in preventing diabetes. The investigators aimed to compare the effects of two fermentable fibers (inulin and resistant-starch) on postprandial SCFA, glucose, insulin, free-fatty acids (FFA) and gut hormone responses and to compare the responses in healthy overweight and obese (OWO) vs lean (LN) participants. Methods: Using a randomized, single blind, crossover design, 13 OWO and 12 LN overnight fasted participants were studied on 3 separate occasions. On each day they consumed a 300 mL drink containing 75g glucose (Control) or 75g glucose plus 24g inulin (IN), or 28.2g resistant-starch (RS). A standard lunch was served 4 h after the test drink.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Obesity

    7. Study Design

    Primary Purpose
    Basic Science
    Study Phase
    Not Applicable
    Interventional Study Model
    Crossover Assignment
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    25 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Lean
    Arm Type
    Other
    Arm Description
    Participants with body mass index <=25
    Arm Title
    Overweight
    Arm Type
    Other
    Arm Description
    Participants with body mass index >25
    Intervention Type
    Other
    Intervention Name(s)
    Glucose
    Intervention Description
    75g glucose
    Intervention Type
    Other
    Intervention Name(s)
    Inulin
    Intervention Description
    75g glucose plus 24g inulin
    Intervention Type
    Other
    Intervention Name(s)
    Resistant Starch
    Intervention Description
    75g glucose plus 28.2g resistant starch
    Primary Outcome Measure Information:
    Title
    Incremental area under the serum acetate response curve
    Time Frame
    For 6 hours after consuming the test meal
    Secondary Outcome Measure Information:
    Title
    Incremental area under the serum propionate response curve
    Time Frame
    For 6 hours after consuming the test meal
    Title
    Incremental area under the serum butyrate response curve
    Time Frame
    For 6 hours after consuming the test meal
    Title
    Incremental area under the breath hydrogen response curve
    Time Frame
    For 6 hours after consuming the test meal
    Title
    Incremental area under the breath methane response curve
    Time Frame
    For 6 hours after consuming the test meal
    Title
    Incremental area under the serum glucose response curve
    Time Frame
    For 4 hours after consuming the test meal
    Title
    Incremental area under the serum glucose response curve
    Time Frame
    For 2 hours after consuming the standard lunch
    Title
    Incremental area under the serum insulin response curve
    Time Frame
    For 4 hours after consuming the test meal
    Title
    Incremental area under the serum insulin response curve
    Time Frame
    For 2 hours after consuming the standard lunch
    Title
    Incremental area under the serum c-peptide response curve
    Time Frame
    For 4 hours after consuming the test meal
    Title
    Incremental area under the serum c-peptide response curve
    Time Frame
    For 2 hours after consuming the standard lunch
    Title
    Total area under the serum free-fatty acid response curve
    Time Frame
    For 4 hours after consuming the test meal
    Title
    Total area under the serum free-fatty acid response curve
    Time Frame
    For 2 hours after consuming the standard lunch
    Other Pre-specified Outcome Measures:
    Title
    Incremental area under the serum glucagon-like peptide-1 response curve
    Time Frame
    For 4 hours after consuming the test meal
    Title
    Incremental area under the serum glucagon-like peptide-1 response curve
    Time Frame
    For 2 hours after consuming the standard lunch
    Title
    Incremental area under the serum peptide-YY response curve
    Time Frame
    For 4 hours after consuming the test meal
    Title
    Incremental area under the serum peptide-YY response curve
    Time Frame
    For 2 hours after consuming the standard lunch
    Title
    Incremental area under the serum ghrelin response curve
    Time Frame
    For 4 hours after consuming the test meal
    Title
    Incremental area under the serum ghrelin response curve
    Time Frame
    For 2 hours after consuming the standard lunch

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    65 Years
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria: non-pregnant body mass index >=20 and <=35 Exclusion Criteria: history of diabetes mellitus history of cardiovascular disease history of bowel disease history of kidney disease history of liver disease use of antibiotics within 3 months of enrolment unusual dietary habits fasting glucose >6.9mmol/L hematocrit below normal range for age and sex
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Thomas MS Wolever, MD, PhD
    Organizational Affiliation
    University of Toronto
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Citations:
    PubMed Identifier
    27966574
    Citation
    Rahat-Rozenbloom S, Fernandes J, Cheng J, Wolever TMS. Acute increases in serum colonic short-chain fatty acids elicited by inulin do not increase GLP-1 or PYY responses but may reduce ghrelin in lean and overweight humans. Eur J Clin Nutr. 2017 Aug;71(8):953-958. doi: 10.1038/ejcn.2016.249. Epub 2016 Dec 14.
    Results Reference
    derived
    PubMed Identifier
    27966565
    Citation
    Rahat-Rozenbloom S, Fernandes J, Cheng J, Gloor GB, Wolever TM. The acute effects of inulin and resistant starch on postprandial serum short-chain fatty acids and second-meal glycemic response in lean and overweight humans. Eur J Clin Nutr. 2017 Feb;71(2):227-233. doi: 10.1038/ejcn.2016.248. Epub 2016 Dec 14.
    Results Reference
    derived

    Learn more about this trial

    Role of Colonic Short Chain Fatty Acids in Obesity

    We'll reach out to this number within 24 hrs